CIK 0001157601 · Large accelerated filer
MADRIGAL PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- MDGL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (267) 824-2827
- Business address
- 1001 CONSHOHOCKEN STATE ROAD, SUITE 2-350, WEST CONSHOHOCKEN, PA
- Former names
- MADRIGAL PHARMACEUTICALS, INC., SYNTA PHARMACEUTICALS CORP
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Option exercise President and CEO acquired 50,000 shares (option exercise)
- 4 Open-market sale Director sold 15,470 shares at an average $347.45 ($5,375,126)
- 4 Open-market sale Director sold 20,000 shares at an average $356.44 ($7,128,759)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 10-K Report Annual Report
- 8-K Event Results of operations
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 4 Open-market sale Chief Commercial Officer sold 347 shares at $335.24 ($116,328)
- 4 Open-market sale President and CEO sold 1,584 shares at $335.24 ($531,020)
- 4 Open-market sale Pres., R&D, and CMO sold 648 shares at $335.24 ($217,236)
- 4 Open-market sale Senior VP, Chief Pharma Dev. sold 103 shares at $335.24 ($34,530)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
Page 10 of 62 · 1,224 filings